Just as mesothelioma patients are taking a collective sigh of relief at the fading of COVID-19, health officials are sounding the alarm about this year’s flu. Those warnings are particularly important for those diagnosed with the rare and deadly form of cancer.
The challenges of treating malignant mesothelioma are well known. The rare and fatal form of cancer is notoriously resistant to traditional protocols, and historically most patients die within a year of their diagnosis. But a recent study conducted by researchers in Japan has shown that administering chemotherapy prior to surgery is an extremely effective option
Though mesothelioma researchers are far from finding a cure for the rare and fatal asbestos-related disease, they’ve found that combining existing therapies can significantly extend patient survival. A recent study shows that by combining heated chemotherapy with a surgical procedure known as extended pleurectomy with decortication, patients were able to live far longer than what
When you’ve been diagnosed with malignant pleural mesothelioma, your instinct may be to take your time and weigh your medical options. Unfortunately, the aggressive nature of the asbestos-related disease means decisions need to be made quickly, including regarding the type of surgery to have. With both available approaches that each offer advantages and disadvantages, the
Paul Hotard died of malignant mesothelioma despite never having worked directly with asbestos. The shipyard worker spent years working for Avondale Shipyards, where he handed pipe to pipefitters and tacked pipe together for a welder to weld. He blamed SeaRiver Maritime, the owner of the vessels on which he worked, for failing to warn him
Carpenters regularly risked asbestos exposure on the job, which increased their risk of mesothelioma. Today, many of these workers, and people doing DIY work or woodworking projects on their homes are still at risk because asbestos lingers in older buildings. Victims of asbestos exposure in carpentry and construction could be eligible for compensation. How Do
Patients diagnosed with malignant pleural mesothelioma are quickly assessed to determine whether they are eligible for one of two methods of surgical resection of their tumors: either the lung-sparing pleurectomy with decortication or a more aggressive approach called extrapleural pneumonectomy, which removes the pleural membrane and the affected lung, as well as any other impacted
Not every patient diagnosed with malignant pleural mesothelioma is eligible for surgery, but those who are surgical candidates face a significant dilemma. Should they opt for extrapleural pneumonectomy, an aggressive surgery that removes the pleural membrane, the most affected lung, and all evidence of cancer? Or should they choose the less invasive pleurectomy and decortication
There are certain things that almost all pleural mesothelioma victims have in common before their diagnosis: chest pain; coughing, weight loss, fatigue. In response to these symptoms, physicians conduct extensive tests to ensure a proper diagnosis. Though immunohistochemistry can both confirm mesothelioma and distinguish its specific cell type, researchers have found that more extensive testing
Pleurodesis is one of many procedures that patients diagnosed with malignant pleural mesothelioma can expect to undergo. This minor surgery drains fluid that builds up in the space between the pleural lining and the lung, making it easier for patients to breathe. But a new study out of Canada has revealed that the procedure can